Keebeck Wealth Management bought a new position in shares of The Allstate Corporation (NYSE:ALL – Free Report) in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 2,504 shares of the insurance provider’s stock, valued at approximately $598,000.
Other hedge funds have also recently bought and sold shares of the company. MV Capital Management Inc. acquired a new position in shares of Allstate in the fourth quarter valued at approximately $25,000. Gables Capital Management Inc. bought a new stake in shares of Allstate during the second quarter worth $26,000. Navalign LLC acquired a new stake in shares of Allstate during the fourth quarter worth $27,000. Kelleher Financial Advisors acquired a new stake in shares of Allstate during the second quarter worth $28,000. Finally, Evolution Wealth Management Inc. lifted its position in Allstate by 7,000.0% in the 1st quarter. Evolution Wealth Management Inc. now owns 142 shares of the insurance provider’s stock valued at $29,000 after acquiring an additional 140 shares in the last quarter. 76.47% of the stock is currently owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
ALL has been the subject of a number of research analyst reports. Piper Sandler upped their target price on shares of Allstate from $268.00 to $300.00 and gave the stock an “overweight” rating in a research note on Monday, August 10th. Wells Fargo & Company downgraded Allstate from an “equal weight” rating to an “underweight” rating and lifted their price target for the company from $243.00 to $250.00 in a research note on Friday, August 7th. Wall Street Zen raised Allstate from a “hold” rating to a “buy” rating in a research report on Monday, July 20th. Roth Capital set a $300.00 price objective on Allstate in a report on Thursday, August 6th. Finally, HSBC lowered Allstate from a “buy” rating to a “hold” rating and lifted their target price for the company from $244.00 to $264.00 in a research report on Monday, July 6th. Four research analysts have rated the stock with a Strong Buy rating, five have issued a Buy rating, eight have assigned a Hold rating and four have assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $265.26.
Insider Buying and Selling
In related news, COO Mario Rizzo sold 56,225 shares of the stock in a transaction that occurred on Tuesday, August 11th. The stock was sold at an average price of $264.48, for a total transaction of $14,870,388.00. Following the completion of the transaction, the chief operating officer directly owned 82,227 shares of the company’s stock, valued at approximately $21,747,396.96. This represents a 40.61% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider John E. Dugenske sold 32,996 shares of the stock in a transaction that occurred on Friday, August 7th. The shares were sold at an average price of $269.33, for a total value of $8,886,812.68. Following the transaction, the insider directly owned 13,054 shares of the company’s stock, valued at $3,515,833.82. This trade represents a 71.65% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders have sold 91,446 shares of company stock worth $24,208,675. Corporate insiders own 1.55% of the company’s stock.
Allstate News Roundup
Here are the key news stories impacting Allstate this week:
- Positive Sentiment: Zacks Research raised several Allstate EPS forecasts, including estimates for Q3 2026, FY2027, FY2028, Q1 2027, Q4 2027 and Q2 2028. Zacks maintains a “Strong-Buy” rating, supporting the view that underwriting performance and earnings power may remain resilient. Allstate earnings estimates
- Positive Sentiment: A Zacks screen identified ALL as a high-return-on-equity, cash-rich stock that could appeal to investors seeking quality and financial strength during volatile markets. High-ROE stocks article
- Neutral Sentiment: Allstate opened a new Dallas auto laboratory to train claims adjusters on increasingly complex vehicle technology. The initiative could improve claims accuracy and customer service over time, but it is unlikely to materially affect near-term earnings. Allstate Dallas auto lab
- Negative Sentiment: Keefe, Bruyette & Woods downgraded ALL from “hold” to “moderate sell,” adding to investor caution around the stock’s valuation and outlook. Allstate analyst downgrade
- Negative Sentiment: Allstate estimated July catastrophe losses of $682 million pretax, or $539 million after tax. The losses bring pretax catastrophe costs for the current aggregate year to approximately $2.402 billion, creating pressure on underwriting margins and near-term earnings. Allstate July 2026 monthly release
- Negative Sentiment: Zacks Research lowered its Q2 2027 and Q4 2026 EPS estimates, indicating that analysts still see some periods of earnings pressure despite upward revisions elsewhere. Allstate earnings estimates
Allstate Stock Down 0.3%
Shares of ALL stock opened at $253.82 on Friday. The company has a current ratio of 0.36, a quick ratio of 0.36 and a debt-to-equity ratio of 0.24. The Allstate Corporation has a 1 year low of $188.08 and a 1 year high of $277.22. The firm’s fifty day moving average price is $250.34 and its two-hundred day moving average price is $224.95. The firm has a market capitalization of $64.18 billion, a P/E ratio of 5.07, a PEG ratio of 0.39 and a beta of 0.16.
Allstate (NYSE:ALL – Get Free Report) last issued its quarterly earnings results on Wednesday, August 5th. The insurance provider reported $8.99 EPS for the quarter, topping the consensus estimate of $6.06 by $2.93. Allstate had a net margin of 18.97% and a return on equity of 41.64%. The firm had revenue of $18.60 billion for the quarter, compared to analysts’ expectations of $15.46 billion. During the same period in the previous year, the firm posted $5.94 EPS. The company’s revenue for the quarter was up 11.8% on a year-over-year basis. On average, equities analysts predict that The Allstate Corporation will post 34.45 EPS for the current fiscal year.
Allstate Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Thursday, October 1st. Investors of record on Monday, August 31st will be issued a dividend of $1.08 per share. This represents a $4.32 annualized dividend and a yield of 1.7%. The ex-dividend date is Monday, August 31st. Allstate’s dividend payout ratio is presently 8.63%.
About Allstate
Allstate Corporation is a publicly traded insurance company headquartered in Northbrook, Illinois, and is one of the largest personal lines property and casualty insurers in the United States. Founded in 1931 as a subsidiary of Sears, Roebuck and Co, Allstate has grown into a diversified insurer that serves millions of consumers and businesses through a mix of distribution channels and product offerings.
The company underwrites a broad range of insurance products, with primary emphasis on auto and homeowners coverage.
Featured Stories
- Five stocks we like better than Allstate
- Blueprint for a Boom: SEC Clears the Crypto Runway
- Ross Stores Just Flipped the Off-Price Retail Story After TJX’s Marmaxx Miss
- Advance Auto Parts Plunged, But Its Turnaround Is Still Working
- Is Palo Alto Networks Priced for Perfection Again as AI Security Demand Accelerates?
Want to see what other hedge funds are holding ALL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Allstate Corporation (NYSE:ALL – Free Report).
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.
